News

Immunomedics will receive initial cash payments of $38 million and could receive potential milestone payments of up to $145 million in cash and $20 million in equity investments,

The FDA granted the designation because infection with shigatoxin-producing bacteria may result in hemolytic uremic syndrome, a serious condition for which there are no currently available preventative therapies.

The company licensed the rights to commercialize the drug in diabetic neuropathy from North Carolina-based Biostratum, while it acquired the commercial rights to the drug in acute renal

CCR5 antagonists are a new class of antiretroviral compound that have been shown to block entry of the HIV virus into the cell, unlike nearly all of the

GVAX was given the designation as it has shown potential to treat advanced prostate cancer, a life-threatening condition that represents an unmet medical need. The treatment is currently

The purpose of the eight-week study is to assess the efficacy and safety of 20mg of IPL512-602 given once daily as an oral asthma medication. Approximately 200 male

In the study, conducted by Duke University Medical Center, more than 50% of obese patients in the Qnexa treatment group experienced 10% or more total body weight loss

TZP-101 is a selective ghrelin receptor agonist with potent gastroprokinetic properties that represents the first in its class to enter into a clinical trial. The trial was an

Exocrine pancreatic insufficiency (EPI) is a deficiency of digestive enzymes normally produced by the pancreas which leads to malnutrition, impaired growth and shortened life expectancy. EPI can result